You’re using a public version of DrugPatentWatch with 1 free search available | Register to unlock more free searches. CREATE FREE ACCOUNT

Serving leading biopharmaceutical companies globally:

Harvard Business School
Moodys
Medtronic
Johnson and Johnson
Merck
Mallinckrodt

Last Updated: September 22, 2023

Investigational Drug Information for Trehalose-6-Phosphate


✉ Email this page to a colleague

« Back to Dashboard


What is the drug development status for Trehalose-6-Phosphate?

Trehalose-6-Phosphate is an investigational drug.

There have been 17 clinical trials for Trehalose-6-Phosphate. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2022.

The most common disease conditions in clinical trials are Alzheimer Disease, Macular Edema, and Parkinson Disease. The leading clinical trial sponsors are Seelos Therapeutics, Inc., Mashhad University of Medical Sciences, and Bioblast Pharma Ltd.

There are ten US patents protecting this investigational drug and fifty-three international patents.

Recent Clinical Trials for Trehalose-6-Phosphate
TitleSponsorPhase
Role of Autophagy in Type 2 Diabetes Microvascular DysfunctionMedical College of WisconsinEarly Phase 1
STRIDES - a Clinical Research Study of an Investigational New Drug to Treat Spinocerebellar AtaxiaSeelos Therapeutics, Inc.Phase 2/Phase 3
SLS-005 (Trehalose Injection) in the Treatment of Alzheimer's DiseaseSeelos Therapeutics, Inc.Phase 2

See all Trehalose-6-Phosphate clinical trials

Clinical Trial Summary for Trehalose-6-Phosphate

Top disease conditions for Trehalose-6-Phosphate
Top clinical trial sponsors for Trehalose-6-Phosphate

See all Trehalose-6-Phosphate clinical trials

US Patents for Trehalose-6-Phosphate

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Trehalose-6-Phosphate ⤷  Try a Trial Modified gram positive bacteria and uses thereof INTREXON ACTOBIOTICS NV (Zwijnaarde, BE) ⤷  Try a Trial
Trehalose-6-Phosphate ⤷  Try a Trial Processes of producing fermentation products NOVOZYMES A/S (Bagsvaerd, DK) ⤷  Try a Trial
Trehalose-6-Phosphate ⤷  Try a Trial Modified gram positive bacteria and uses thereof INTREXON ACTOBIOTICS NV (Zwijnaarde, BE) ⤷  Try a Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Trehalose-6-Phosphate

Drugname Country Document Number Estimated Expiration Related US Patent
Trehalose-6-Phosphate Denmark DK2758512 2031-09-23 ⤷  Try a Trial
Trehalose-6-Phosphate European Patent Office EP2758512 2031-09-23 ⤷  Try a Trial
Trehalose-6-Phosphate Spain ES2676707 2031-09-23 ⤷  Try a Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Moodys
Medtronic
Johnson and Johnson
Merck
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.